HB2534 Summary

• Amends the Illinois Controlled Substances Act to add numerous synthetic drugs and analogs to Schedule I, including synthetic cannabinoids (cannabinoid-derived compounds), synthetic cathinones, fentanyl analogs (furanyl fentanyl, butyryl fentanyl, acrylfentanyl), and tryptamine derivatives (4-AcO-DMT, 5-MeO-MIPT, methoxetamine).

• Adds 6-monoacetylmorphine and thiafentanyl to Schedule II opiates, and modifies dextromethorphan scheduling to allow OTC drug products in solid form at FDA-approved dosages while restricting other formulations.

• Expands the definition of "controlled substance analog" in manufacturing/delivery and possession statutes to include substances "not approved by the United States Food and Drug Administration or, if approved, not dispensed or possessed in accordance with State or federal law."

• Increases criminal penalties for manufacturing, delivering, or possessing Schedule I hallucinogenic substances (expanded list in Section 204) to Class X felony for large quantities, with sentences ranging from 6-60 years depending on drug type and amount.

• Removes several synthetic cannabinoids and cathinones from specific Schedule I listings while maintaining broader structural class prohibitions that cover designer drug variants.